PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
10-Feb-2021 European Commission Grants Vico Therapeutics Orphan Drug Designation for VO659, an Investigational Therapy for Spinocerebellar Ataxia Vico Therapeutics
10-Feb-2021 Thrombolytic Science Reinforces Its IP Portfolio with Patents in Europe, the Commonwealth of Independent States and Japan Thrombolytic Science, LLC
10-Feb-2021 Takeda Submits New Drug Application to Manufacture and Market Darvadstrocel In Japan for Treatment of Complex Perianal Fistulas in Adult Patients with Crohn’s Disease Takeda
10-Feb-2021 Cell-Freezing Market to be transformed by University of Warwick Spin-Out CryoLogyx CryoLogyx
10-Feb-2021 FDA approves Libtayo® (Cemiplimab-rwlc) as first immunotherapy indicated for patients with advanced basal cell carcinoma Sanofi and Regeneron
10-Feb-2021 Sygnature Discovery & Altasciences Join Forces For New Webinar Series Sygnature Discovery
10-Feb-2021 PTC technology accelerates Watson-Marlow’s digital transformation plans PTC
10-Feb-2021 Biogen’s main MS assets facing increasing competition and further losses in the MS market, says GlobalData Biogen
10-Feb-2021 Thrombolytic Science Reinforces Its IP Portfolio with Patents in Europe, the Commonwealth of Independent States and Japan B3C newswire
10-Feb-2021 Oxular Limited Appoints Dr. Jatinder Kapur as Vice President of Quality Oxular
10-Feb-2021 XPhyto Therapeutics Corp.: XPhyto Adds Mescaline Production to Psychedelic Medicine Programs XPhyto Therapeutics Corp.
10-Feb-2021 European Commission Grants Vico Therapeutics Orphan Drug Designation for VO659, an Investigational Therapy for Spinocerebellar Ataxia B3C newswire
10-Feb-2021 Relief Confirms Release of Preliminary Findings from Phase 2b/3 Trial of Intravenous RLF-100(TM) (aviptadil) RELIEF THERAPEUTICS Holdings AG
09-Feb-2021 OncoZenge has obtained a conditional approval for listing on Nasdaq First North Growth Market and publishes prospectus OncoZenge
09-Feb-2021 Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies at the 17th Annual WORLDSymposium™ Freeline Therapeutics Holdings plc
09-Feb-2021 Nanoform and Herantis sign Biologics Proof of Concept Agreement Nanoform
09-Feb-2021 Anticancer Bioscience Announces CNY63m (~USD10m) Financing to Advance its Synthetic Lethal Platform and Pre-clinical Oncology Pipeline Anticancer Bioscience
09-Feb-2021 SMC Issues Positive Decision for Treatment with AbbVie’s RINVOQ®▼(upadacitinib) in Severe Active Rheumatoid Arthritis (RA) Scottish Medicines Consortium
09-Feb-2021 SCOTTISH APPROVAL OF A NEW TREATMENT FOR PEOPLE WITH CHRONIC PULMONARY RESPIRATORY DISEASE (COPD) - FORMOTEROL FUMARATE DIHYDRATE/GLYCOPYRRONIUM BROMIDE/BUDESONIDE[i] AstraZeneca
09-Feb-2021 Janssen Announces Treatment with ERLEADA® (apalutamide) Significantly Improved Overall Survival in Patients with Metastatic Hormone-Sensitive Prostate Cancer Janssen